So, Tamiflu was about 8% of their sales and accounted for a 5% increase in revenue. Not a bad short term boost.
Epidemiologists are caught in a bind.
On one hand, they can become the "boy who cried wolf". Eventually nobody will believe the warnings.
On the other hand, there is a real...